Valuation · US stocks

Gilead Sciences, Inc. (GILD) valuation

As of 2026-11-18, Gilead Sciences, Inc. trades at $168.98, above the highest fair-value bound of its 1, 3 and 5-year windows.

Price
$168.98
Day change
-0.75%
Market cap
$181.83B
Sector
Biotechnology
Valuation
Above band
Fair value
Sign up free to see the fair value and gap
As of
2026-11-18
Open the full valuation in Wave Radar

Options

Options price a move of ±4.18% to the 2026-11-20 expiry (implied volatility 37.65%). GILD gamma exposure

Other Biotechnology stocks

StockPriceMarket capValuation
Amgen Inc. AMGN$443.89$251.94BHigh
Moderna, Inc. MRNA$196.79$93.61BAbove band
Natera, Inc. NTRA$289.50$44.78BFair
IQVIA Holdings Inc IQV$257.80$42.67BAbove band
United Therapeutics Corporation UTHR$577.34$24.09BAbove band
Neurocrine Biosciences, Inc. NBIX$162.86$16.76BFair
Summit Therapeutics Inc SMMT$10.50$13.99BFair
Elanco Animal Health, Inc. ELAN$26.69$13.41BAbove band
Halozyme Therapeutics, Inc. HALO$95.80$11.76BHigh
Twist Bioscience Corp. TWST$116.35$11.50BAbove band
Bio-Techne Corporation TECH$72.75$11.44BFair
BioMarin Pharmaceutical Inc. BMRN$61.43$10.77BFair

How the valuation band works

Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.

Read the method

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.